ACL vs NEU

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

ACL

AUCLINICAL FPO [ACL]

44LOW

NEU

NEUREN FPO NZ [NEU]

44LOW

Score Breakdown

ACL NEU
Technical
65
77
Catalyst
50
50
Sentiment
50
50
Fundamental
73
60
Momentum
37
22
Risk Gate
36
43

Key Metrics

ACL Metric NEU
$372.1MMarket Cap$1.5B
626KAvg Volume (20d)705K
+6.1%Short Interest+4.4%
$3.24052-Week High$22.985
$1.91552-Week Low$8.610
+2.8%Daily Change+5.1%
$2.010Entry Price$11.880
+16.7%ROE+8.7%
+3.6%Profit Margin+47.1%

Active Signals

ACL Signals

●RSI drifting toward oversold territory — worth watching
●MACD just crossed bullish — momentum is shifting to the upside
●Above-average volume (1.8x) on a green day — buyers stepping up
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.5x)
●EPS estimates revised upward (+10pts)
●Post-earnings drift: negative surprise (SUE -10)

NEU Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Stochastic just turned bullish from a low level — early reversal sign
●Above-average volume (1.8x) on a green day — buyers stepping up
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Revenue in sharp decline (-81%)

Ask Scout AI to compare ACL and NEU in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
ACL Full Analysis → NEU Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).